Comparative Analysis of ESBL Phenotypes and Antimicrobial Resistance in Escherichia coli Associated with Urinary Tract Infections and in Commensal Strains.

IF 1.9 4区 医学 Q3 INFECTIOUS DISEASES
Denyss Guilcazo, Lazaro López, Diana Calderón, Katherine Vasquez, Cristina Chávez, Lance B Price, Jay P Graham, Joseph Eisenberg, Gabriel Trueba
{"title":"Comparative Analysis of ESBL Phenotypes and Antimicrobial Resistance in <i>Escherichia coli</i> Associated with Urinary Tract Infections and in Commensal Strains.","authors":"Denyss Guilcazo, Lazaro López, Diana Calderón, Katherine Vasquez, Cristina Chávez, Lance B Price, Jay P Graham, Joseph Eisenberg, Gabriel Trueba","doi":"10.1177/10766294251386346","DOIUrl":null,"url":null,"abstract":"<p><p><i>Escherichia coli</i> is a genetically versatile organism capable of thriving in diverse environments, acting as a commensal in the intestine or as a pathogen in the urinary tract. <i>E. coli</i> causing urinary tract infections has acquired genes that enable it to colonize the urinary tract, survive immune response, and resist antimicrobials. In this study, we investigated the association between the ESBL (Extended Spectrum Beta Lactamase) phenotype and other antimicrobial resistances in <i>E. coli</i> associated with urinary tract infections (UTI-<i>E. coli</i>; <i>n</i> = 1,139) and compared them with commensal <i>E. coli</i> strains (<i>n</i> = 405) isolated from human fecal samples in the same communities and during the same period. Among UTI-<i>E. coli</i> strains, 16.9% were ESBL producers compared to 7.6% in commensal strains, and resistance to other antimicrobials was also significantly higher in UTI-<i>E. coli</i>. These results suggest that many UTI-<i>E. coli</i> and commensal <i>E. coli</i> lineages have been subjected to distinct antimicrobial pressures over time.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial drug resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10766294251386346","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Escherichia coli is a genetically versatile organism capable of thriving in diverse environments, acting as a commensal in the intestine or as a pathogen in the urinary tract. E. coli causing urinary tract infections has acquired genes that enable it to colonize the urinary tract, survive immune response, and resist antimicrobials. In this study, we investigated the association between the ESBL (Extended Spectrum Beta Lactamase) phenotype and other antimicrobial resistances in E. coli associated with urinary tract infections (UTI-E. coli; n = 1,139) and compared them with commensal E. coli strains (n = 405) isolated from human fecal samples in the same communities and during the same period. Among UTI-E. coli strains, 16.9% were ESBL producers compared to 7.6% in commensal strains, and resistance to other antimicrobials was also significantly higher in UTI-E. coli. These results suggest that many UTI-E. coli and commensal E. coli lineages have been subjected to distinct antimicrobial pressures over time.

尿路感染相关大肠埃希菌与共生菌株ESBL表型及耐药性比较分析
大肠杆菌是一种基因多样的有机体,能够在不同的环境中茁壮成长,在肠道中作为共生体或在泌尿道中作为病原体。引起尿路感染的大肠杆菌已经获得了能够在尿路定植、在免疫反应中存活并抵抗抗菌剂的基因。在这项研究中,我们研究了ESBL(扩展谱β -内酰胺酶)表型与尿路感染相关大肠杆菌(UTI-E)其他抗菌素耐药性之间的关系。杆菌;n = 1139),并将其与从同一社区和同一时期的人类粪便样本中分离的共生大肠杆菌菌株(n = 405)进行比较。UTI-E之一。大肠杆菌菌株中,16.9%产生ESBL,而共生菌株为7.6%,并且对其他抗菌素的耐药性也显著高于UTI-E。杆菌。这些结果表明许多UTI-E。随着时间的推移,大肠杆菌和共生大肠杆菌谱系受到不同的抗菌压力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Microbial drug resistance
Microbial drug resistance 医学-传染病学
CiteScore
6.00
自引率
3.80%
发文量
118
审稿时长
6-12 weeks
期刊介绍: Microbial Drug Resistance (MDR) is an international, peer-reviewed journal that covers the global spread and threat of multi-drug resistant clones of major pathogens that are widely documented in hospitals and the scientific community. The Journal addresses the serious challenges of trying to decipher the molecular mechanisms of drug resistance. MDR provides a multidisciplinary forum for peer-reviewed original publications as well as topical reviews and special reports. MDR coverage includes: Molecular biology of resistance mechanisms Virulence genes and disease Molecular epidemiology Drug design Infection control.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信